|
|
|

|
|
|
Journal of Histochemistry and Cytochemistry, Vol. 51, 349-361, March 2003, Copyright © 2003, The Histochemical Society, Inc.
Induction of a Storage Phenotype and Abnormal Intracellular Localization of Apical Glycoproteins Are Two Independent Responses to GalNAc -O-bn
Emmanuelle Leteurtrea,b,
Valérie Gouyera,
Delphine Delacoura,
Brigitte Hémona,
Alexandre Ponsc,
Colette Richeta,
Jean-Pierre Zanettac, and
Guillemette Hueta
a Unité INSERM 560, Villeneuve d'Ascq, France
b Service d'Anatomie Pathologique, Villeneuve d'Ascq, France
c Lille, France, and Unité de Glycobiologie Structurale et Fonctionnelle, UMR CNRS 8576, Laboratoire de Chimie Biologique, Université des Sciences et Technologies de Lille, Villeneuve d'Ascq, France
Correspondence to:
Guillemette Huet, Unité INSERM 560, Place de Verdun, 59045 Lille cedex, France. E-mail: huet@lille.inserm.fr
Our previous studies on an inhibitor of O-glycosylation of glycoproteins, GalNAc -O-bn, in the model of enterocytic HT-29 cells, have shown at the cellular level an alteration of the normal localization of apical glycoproteins, and at the biochemical level an in situ synthesis and storage of sialylated GalNAc -O-bn oligosaccharides. The purpose of this study was to examine if a relation existed between these two events, using different cell lines. Intracellular storage of GalNAc -O-bn metabolites occurred in HT-29 and CAPAN-1 cells but not in Caco-2 cells. On the other hand, an accumulation of endosomal/lysosomal compartments was observed in HT-29 and CAPAN-1 cells but not in Caco-2 cells. These data focused on a GalNAc -O-bn-derived storage phenotype in HT-29 and CAPAN-1 cells. The apical membrane glycoproteins MUC1 and CEA showed an abnormal localization inside intracytoplasmic vesicles in HT-29 cells, whereas they kept their normal localization in Caco-2 and CAPAN-1 cells. Studies on the glycosylation of these apical glycoproteins showed that GalNAc -O-bn inhibited the glycosylation in a cell-specific manner. The alteration in the apical targeting of glycoproteins, and the appearance of a GalNAc -O-bn-derived storage phenotype are two independent and cell type-specific events. The former depends on the inhibition pattern of the glycosylation of endogenous glycoproteins, whereas the latter is connected to the intracellular accumulation of GalNAc -O-bn metabolites.
(J Histochem Cytochem 51:349361, 2003)
Key Words:
glycoproteins, inhibitor, GalNAc -O-bn, apical membranes, glycosylation

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
G. Patsos, V. Hebbe-Viton, C. Robbe-Masselot, D. Masselot, R. S. Martin, R. Greenwood, C. Paraskeva, A. Klein, M. Graessmann, J. C. Michalski, et al.
O-Glycan inhibitors generate aryl-glycans, induce apoptosis and lead to growth inhibition in colorectal cancer cell lines
Glycobiology,
April 1, 2009;
19(4):
382 - 398.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Delacour, V. Gouyer, E. Leteurtre, T. Ait-Slimane, H. Drobecq, C. Lenoir, O. Moreau-Hannedouche, G. Trugnan, and G. Huet
1-Benzyl-2-acetamido-2-deoxy-{alpha}-D-galactopyranoside Blocks the Apical Biosynthetic Pathway in Polarized HT-29 Cells
J. Biol. Chem.,
September 26, 2003;
278(39):
37799 - 37809.
[Abstract]
[Full Text]
[PDF]
|
 |
|
The Journal of Histochemistry & Cytochemistry
is owned, published, and licensed by
The Histochemical Society © 2003
|
|
|